Shengna Han

977 total citations
47 papers, 703 citations indexed

About

Shengna Han is a scholar working on Molecular Biology, Cancer Research and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Shengna Han has authored 47 papers receiving a total of 703 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 13 papers in Cancer Research and 12 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Shengna Han's work include RNA modifications and cancer (12 papers), Cancer-related molecular mechanisms research (10 papers) and Cardiac electrophysiology and arrhythmias (8 papers). Shengna Han is often cited by papers focused on RNA modifications and cancer (12 papers), Cancer-related molecular mechanisms research (10 papers) and Cardiac electrophysiology and arrhythmias (8 papers). Shengna Han collaborates with scholars based in China, United States and Pakistan. Shengna Han's co-authors include Lirong Zhang, Jianjian Yin, Shuhui Wang, Jianzeng Dong, Ming‐Xi Zang, Shuang Yu, Wei-Hong Yang, Xiao‐bo Zhong, Shuhui Wang and Yanyan Duan and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Journal of Medicinal Chemistry and Carbohydrate Polymers.

In The Last Decade

Shengna Han

44 papers receiving 691 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shengna Han China 15 468 176 173 63 59 47 703
Shanhong Lu China 13 254 0.5× 93 0.5× 132 0.8× 48 0.8× 58 1.0× 24 647
Gaoxiang Ma China 13 332 0.7× 67 0.4× 63 0.4× 59 0.9× 44 0.7× 33 612
Zhulan Cai China 12 251 0.5× 127 0.7× 63 0.4× 62 1.0× 26 0.4× 16 425
Lanfeng Wang China 15 385 0.8× 112 0.6× 61 0.4× 70 1.1× 72 1.2× 25 778
Sebastián D. Calligaris Chile 14 433 0.9× 143 0.8× 92 0.5× 29 0.5× 40 0.7× 23 831
Hai‐Yan Qian China 11 243 0.5× 74 0.4× 58 0.3× 48 0.8× 60 1.0× 21 547
Ahmed Lawan United States 12 365 0.8× 55 0.3× 69 0.4× 60 1.0× 49 0.8× 24 563
Jinque Luo China 14 233 0.5× 58 0.3× 54 0.3× 80 1.3× 41 0.7× 28 541

Countries citing papers authored by Shengna Han

Since Specialization
Citations

This map shows the geographic impact of Shengna Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengna Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengna Han more than expected).

Fields of papers citing papers by Shengna Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengna Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengna Han. The network helps show where Shengna Han may publish in the future.

Co-authorship network of co-authors of Shengna Han

This figure shows the co-authorship network connecting the top 25 collaborators of Shengna Han. A scholar is included among the top collaborators of Shengna Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengna Han. Shengna Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Tao, Peng Yuan, Jianjian Yin, et al.. (2025). DSG3 promotes bladder cancer growth and metastasis via AKT/GSK3β/β-catenin pathway. Journal of Translational Medicine. 23(1). 729–729. 1 indexed citations
2.
Wang, Jingya, Yihang Yu, Zijing Wang, et al.. (2025). METTL3 regulates rifampicin-induced CYP3A4 expression by activating PXR translation and nuclear import and stabilizing CYP3A4 mRNA. Biochemical Pharmacology. 239. 117016–117016.
3.
Wang, Yi‐Ting, Qi Wang, Xiaofei Wang, et al.. (2024). The long noncoding RNA HNF1A-AS1 with dual functions in the regulation of cytochrome P450 3A4. Biochemical Pharmacology. 220. 116016–116016. 9 indexed citations
4.
Gao, Yuan, et al.. (2024). Epigenetic Regulation in Myocardial Fibroblasts and Its Impact on Cardiovascular Diseases. Pharmaceuticals. 17(10). 1353–1353. 5 indexed citations
5.
6.
Yin, Jianjian, Shuhui Wang, Yuejiao Zhou, et al.. (2024). Targeting the ALKBH5-NLRP3 positive feedback loop alleviates cardiomyocyte pyroptosis after myocardial infarction. European Journal of Pharmacology. 989. 177247–177247. 3 indexed citations
7.
Han, Shengna, et al.. (2023). Epigenetic Regulation of Macrophage Polarization in Cardiovascular Diseases. Pharmaceuticals. 16(2). 141–141. 20 indexed citations
8.
Wang, Shuhui, Chunli Liu, Jingmin Wang, et al.. (2023). Ticagrelor reduces doxorubicin-induced pyroptosis of rat cardiomyocytes by targeting GSK-3β/caspase-1. Frontiers in Cardiovascular Medicine. 9. 1090601–1090601. 5 indexed citations
9.
Liu, Guang‐Ming, Qi Chang, Mengyao Yan, et al.. (2023). Prenatal Lipopolysaccharide Exposure Alters Hepatic Drug-Metabolizing Enzyme Expression in Mouse Offspring via Histone Modifications. Toxics. 11(1). 82–82. 1 indexed citations
10.
11.
Li, Weidong, et al.. (2022). Comprehensive analysis of RNA m6A methylation in pressure overload-induced cardiac hypertrophy. BMC Genomics. 23(1). 576–576. 10 indexed citations
12.
Arumugam, Suyavaran, Yanqin Qin, Ziwen Liang, et al.. (2022). GSK3β mediates the spatiotemporal dynamics of NLRP3 inflammasome activation. Cell Death and Differentiation. 29(10). 2060–2069. 35 indexed citations
13.
Zhang, Lirong, et al.. (2021). Potential regulatory role of epigenetic RNA methylation in cardiovascular diseases. Biomedicine & Pharmacotherapy. 137. 111376–111376. 34 indexed citations
14.
Wang, Yi‐Ting, Xiaofei Wang, Yan Liang, et al.. (2021). The Long Noncoding RNA Hepatocyte Nuclear Factor 4α Antisense RNA 1 Negatively Regulates Cytochrome P450 Enzymes in Huh7 Cells via Histone Modifications. Drug Metabolism and Disposition. 49(5). 361–368. 14 indexed citations
15.
Chang, Cheng, Shuhui Wang, Lina Xu, et al.. (2021). Glycogen synthase kinase 3 beta inhibitor SB216763 improves Kir2.1 expression after myocardia infraction in rats. Journal of Interventional Cardiac Electrophysiology. 63(2). 239–248. 7 indexed citations
16.
Xu, Lina, et al.. (2021). Targeting Glycogen Synthase Kinase 3 Beta Regulates CD47 Expression After Myocardial Infarction in Rats via the NF-κB Signaling Pathway. Frontiers in Pharmacology. 12. 662726–662726. 5 indexed citations
17.
Han, Shengna, et al.. (2019). Drug Treatment of Hyperlipidemia in Chinese Patients: Focus on the Use of Simvastatin and Ezetimibe Alone and in Combination. American Journal of Cardiovascular Drugs. 19(3). 237–247. 9 indexed citations
18.
Han, Shengna, Yu Zhang, Xiaoyan Sun, et al.. (2014). Identification and functional characterization of the human ether-a-go-go-related gene Q738X mutant associated with hereditary long QT syndrome type 2. International Journal of Molecular Medicine. 34(3). 810–815. 1 indexed citations
19.
Fan, Tianli, Fang Tian, Shanyong Yi, et al.. (2013). Implications of Bit1 and AIF overexpressions in esophageal squamous cell carcinoma. Tumor Biology. 35(1). 519–527. 12 indexed citations
20.
Guo, Jia, et al.. (2010). The Action of a Novel Fluoroquinolone Antibiotic Agent Antofloxacin Hydrochloride on Human‐Ether‐à‐go‐go‐Related Gene Potassium Channel. Basic & Clinical Pharmacology & Toxicology. 107(2). 643–649. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shanhong Lu Breakdown of academic impact, for papers by Gaoxiang Ma Breakdown of academic impact, for papers by Zhulan Cai Breakdown of academic impact, for papers by Lanfeng Wang Breakdown of academic impact, for papers by Sebastián D. Calligaris Breakdown of academic impact, for papers by Hai‐Yan Qian Breakdown of academic impact, for papers by Ahmed Lawan Breakdown of academic impact, for papers by Jinque Luo
Rankless by CCL
2026